Boothbay Fund Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-85,649
| Closed | -$492K | – | 1332 |
|
|
2024
Q4 | $492K | Sell |
85,649
-63,776
| -43% | -$367K | 0.01% | 735 |
|
|
2024
Q3 | $1.55M | Sell |
149,425
-333,851
| -69% | -$3.46M | 0.04% | 507 |
|
|
2024
Q2 | $6.27M | Buy |
483,276
+94,676
| +24% | +$1.23M | 0.15% | 135 |
|
|
2024
Q1 | $6.78M | Buy |
+388,600
| New | +$6.78M | 0.13% | 124 |
|
|
2020
Q3 | – | Sell |
-20,000
| Closed | -$1M | – | 971 |
|
|
2020
Q2 | $1M | Sell |
20,000
-4,000
| -17% | -$201K | 0.07% | 316 |
|
|
2020
Q1 | $1.23M | Sell |
24,000
-4,000
| -14% | -$206K | 0.1% | 211 |
|
|
2019
Q4 | $1.73M | Hold |
28,000
| – | – | 0.15% | 159 |
|
|
2019
Q3 | $1.68M | Buy |
28,000
+12,000
| +75% | +$721K | 0.15% | 144 |
|
|
2019
Q2 | $1.35M | Buy |
+16,000
| New | +$1.35M | 0.12% | 156 |
|